Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fatty acid synthase activity has been shown to be regulated mainly at the transcriptional level under both dietary and hormonal influences. As a first step towards elucidating the factors involved, we isolated and characterized chicken genomic clones encompassing the 5' part of the chicken fatty acid synthase gene and its flanking region. The entire region of the cloned DNA spans 30 kb, and the first three exons of the gene were mapped to a 6.3-kb genomic fragment. The transcription initiation site was determined after subcloning the cDNA which encodes the 5' end of the mRNA. The first exon, which was 129 bp long, was located approximately 5.3 kb upstream of the second exon, which contained the start codon. In the 5' flanking region, putative TATA and CAAT boxes were located 30 and 92 bp, respectively, upstream of the transcription initiation site. The 5' flanking region contained numerous sequences corresponding to consensus binding sites for transcription factors. Various lengths of flanking sequences extending up to 1028 bp upstream of the transcription initiation site and containing 100 bp of the first exon were linked to the bacterial
chloramphenicol acetyltransferase
gene; in this study, these constructs were analyzed in transient transfection assays in human hepatoma cells. The proximal 125-bp sequence upstream of the transcription start site was shown to be a basal promoter. The cloning and characterization of the chicken
fatty-acid synthase
gene provides some further insight into the regulation of fatty acid synthesis in birds as compared to mammals.
...
PMID:Characterization of the chicken fatty acid synthase gene 5' part and promoter region. 884 94
We previously reported that 2.1 kilobase pairs of the 5'-flanking sequence are sufficient for tissue-specific and hormonal/metabolic regulation of the
fatty-acid synthase
(
FAS
) gene in transgenic mice. We also demonstrated that the -65 E-box is required for insulin regulation of the
FAS
promoter using 3T3-L1 adipocytes in culture. To further define sequences required for
FAS
gene expression, we generated transgenic mice carrying from -644, -444, -278, and -131 to +67 base pairs of the rat
FAS
5'-flanking sequence fused to the
chloramphenicol acetyltransferase
(
CAT
) reporter gene. Similar to the expression observed with -2100-
FAS
-
CAT
transgenic mice, transgenic mice harboring -644-
FAS
-
CAT
and -444-
FAS
-
CAT
expressed high levels of
CAT
mRNA only in lipogenic tissues (liver and adipose tissue) in a manner identical to the endogenous
FAS
mRNA. In contrast, -278-
FAS
-
CAT
and -131-
FAS
-
CAT
transgenic mice did not show appreciable
CAT
expression in any of the tissues examined. When previously fasted mice were refed a high carbohydrate, fat-free diet,
CAT
mRNA expression in transgenic mice harboring -644-
FAS
-
CAT
and -444-
FAS
-
CAT
was induced dramatically in liver and adipose tissue. The induction was virtually identical to that observed in -2100-
FAS
-
CAT
transgenic mice and to the endogenous
FAS
mRNA. In contrast, -278-
FAS
-
CAT
transgenic mice showed induction by feeding, but at a much lower magnitude in both liver and adipose tissue. The -131-
FAS
-
CAT
transgenic mice did not show any
CAT
expression either when fasted or refed a high carbohydrate diet. To study further the effect of insulin, we made these transgenic mice insulin-deficient by streptozotocin treatment. Insulin administration to the streptozotocin-diabetic mice increased
CAT
mRNA levels driven by the -644
FAS
and -444
FAS
promoters in liver and adipose tissue, paralleling the endogenous
FAS
mRNA levels. In the case of -278-
FAS
-
CAT
, the induction observed was at a much lower magnitude, and deletion to -131 base pairs did not show any increase in
CAT
expression by insulin. This study demonstrates that the sequence requirement for
FAS
gene regulation employing an in vitro culture system does not reflect the in vivo situation and that two 5'-flanking regions are required for proper nutritional and insulin regulation of the
FAS
gene. Cotransfection of the upstream stimulatory factor and various
FAS
promoter-luciferase constructs as well as in vitro binding studies suggest a function for the upstream stimulatory factor at both the -65 and -332 E-box sequences.
...
PMID:Two 5'-regions are required for nutritional and insulin regulation of the fatty-acid synthase promoter in transgenic mice. 1074 93